BTN3A2 and depressive symptom measurement: Our findings confirmed previous evidence for TNXB- and NCAM1 in the pathophysiology of depression and suggested four new potential candidate genes (LTBP3, BTN3A2, DAG1 and FHIT) that warrant further investigation.